185 related articles for article (PubMed ID: 20859134)
1. Targeted therapy for advanced thymic tumors.
Rajan A; Giaccone G
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S361-4. PubMed ID: 20859134
[TBL] [Abstract][Full Text] [Related]
2. Molecular aspects of thymic carcinoma.
Weissferdt A; Wistuba II; Moran CA
Lung Cancer; 2012 Nov; 78(2):127-32. PubMed ID: 22921473
[TBL] [Abstract][Full Text] [Related]
3. A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma.
Gbolahan OB; Porter RF; Salter JT; Yiannoutsos C; Burns M; Chiorean EG; Loehrer PJ
J Thorac Oncol; 2018 Dec; 13(12):1940-1948. PubMed ID: 30121390
[TBL] [Abstract][Full Text] [Related]
4. The role of chemotherapy in advanced thymoma.
Schmitt J; Loehrer PJ
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S357-60. PubMed ID: 20859133
[TBL] [Abstract][Full Text] [Related]
5. The multidisciplinary approach to thymoma: combining molecular and clinical approaches.
Chau NG; Kim ES; Wistuba I
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S313-7. PubMed ID: 20859125
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy for thymic carcinoma].
Okuma Y
Gan To Kagaku Ryoho; 2012 May; 39(5):702-7. PubMed ID: 22584319
[TBL] [Abstract][Full Text] [Related]
7. Current Drug Targets for Thymic Neoplasms.
Xu XL; Mao WM
Curr Cancer Drug Targets; 2015; 15(7):593-603. PubMed ID: 26077729
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas.
Giaccone G; Rajan A; Ruijter R; Smit E; van Groeningen C; Hogendoorn PC
J Thorac Oncol; 2009 Oct; 4(10):1270-3. PubMed ID: 20197733
[TBL] [Abstract][Full Text] [Related]
9. Impressive response with imatinib in a heavily pretreated patient with metastatic c-KIT mutated thymic carcinoma.
Buti S; Donini M; Sergio P; Garagnani L; Schirosi L; Passalacqua R; Rossi G
J Clin Oncol; 2011 Nov; 29(33):e803-5. PubMed ID: 21969494
[No Abstract] [Full Text] [Related]
10. Chemotherapy and targeted agents for thymic malignancies.
Girard N
Expert Rev Anticancer Ther; 2012 May; 12(5):685-95. PubMed ID: 22594902
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of single agent amrubicin in patients with previously treated advanced thymic malignancies.
Hellyer JA; Gubens MA; Cunanan KM; Padda SK; Burns M; Spittler AJ; Riess JW; San Pedro-Salcedo M; Ramchandran KJ; Neal JW; Wakelee HA; Loehrer PJ
Lung Cancer; 2019 Nov; 137():71-75. PubMed ID: 31557562
[TBL] [Abstract][Full Text] [Related]
12. Thymic carcinoma with overexpression of mutated KIT and the response to imatinib.
Ströbel P; Hartmann M; Jakob A; Mikesch K; Brink I; Dirnhofer S; Marx A
N Engl J Med; 2004 Jun; 350(25):2625-6. PubMed ID: 15201427
[No Abstract] [Full Text] [Related]
13. Thymoma and thymic carcinoma: molecular pathology and targeted therapy.
Ströbel P; Hohenberger P; Marx A
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S286-90. PubMed ID: 20859121
[TBL] [Abstract][Full Text] [Related]
14. Activating c-KIT mutations in a subset of thymic carcinoma and response to different c-KIT inhibitors.
Schirosi L; Nannini N; Nicoli D; Cavazza A; Valli R; Buti S; Garagnani L; Sartori G; Calabrese F; Marchetti A; Buttitta F; Felicioni L; Migaldi M; Rea F; Di Chiara F; Mengoli MC; Rossi G
Ann Oncol; 2012 Sep; 23(9):2409-2414. PubMed ID: 22357254
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
Thomas A; Rajan A; Berman A; Tomita Y; Brzezniak C; Lee MJ; Lee S; Ling A; Spittler AJ; Carter CA; Guha U; Wang Y; Szabo E; Meltzer P; Steinberg SM; Trepel JB; Loehrer PJ; Giaccone G
Lancet Oncol; 2015 Feb; 16(2):177-86. PubMed ID: 25592632
[TBL] [Abstract][Full Text] [Related]
16. When a thymic carcinoma "becomes" a GIST.
Rossi V; Donini M; Sergio P; Passalacqua R; Rossi G; Buti S
Lung Cancer; 2013 Apr; 80(1):106-8. PubMed ID: 23375402
[TBL] [Abstract][Full Text] [Related]
17. [Medical treatment for thymoma: an update].
Lalle M; Bellini V; Antimi M
Clin Ter; 2008; 159(2):91-5. PubMed ID: 18463767
[TBL] [Abstract][Full Text] [Related]
18. The role of chemotherapy in invasive thymoma: a review of the literature and considerations for future clinical trials.
Tomiak EM; Evans WK
Crit Rev Oncol Hematol; 1993 Oct; 15(2):113-24. PubMed ID: 8117414
[No Abstract] [Full Text] [Related]
19. Chemotherapy for thymic carcinoma and advanced thymoma in adults.
Wei ML; Kang D; Gu L; Qiu M; Zhengyin L; Mu Y
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD008588. PubMed ID: 23970462
[TBL] [Abstract][Full Text] [Related]
20. Systemic treatment of advanced thymic malignancies.
Kelly RJ
Am Soc Clin Oncol Educ Book; 2014; ():e367-73. PubMed ID: 24857125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
